JAK inhibitor CHZ868, Purity ≥98%

Synonym: CHZ868; 1895895-38-1; CHZ-868; N-[4-[2-(2,4-Difluoroanilino)-1,4-dimethylbenzimidazol-5-yl]oxypyridin-2-yl]acetamide; JAK inhibitor

Product Size

2 mg; 5 mg; 10 mg; 25 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

CHZ868 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK2.

Molecular Weight

423.42

Molecular Formula

C₂₂H₁₉F₂N₅O₂

Targets

JAK2: 110 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

CHZ868 is employed to explore selective JAK2 inhibition and its applicability in treating myeloproliferative neoplasms.

Storage

Store at -20ºC.